P3 Health Partners (NASDAQ:PIII) Given New $3.00 Price Target at TD Cowen
by Sarita Garza · The Markets DailyP3 Health Partners (NASDAQ:PIII – Get Free Report) had its target price cut by analysts at TD Cowen from $8.00 to $3.00 in a research note issued on Thursday,Benzinga reports. The firm currently has a “hold” rating on the stock. TD Cowen’s price target would indicate a potential upside of 11.52% from the company’s current price.
PIII has been the subject of several other reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of P3 Health Partners in a research report on Thursday, January 22nd. BTIG Research reaffirmed a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. Finally, Lake Street Capital cut their price objective on P3 Health Partners from $12.50 to $4.00 and set a “buy” rating for the company in a report on Friday, March 27th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $3.50.
Get Our Latest Report on P3 Health Partners
P3 Health Partners Price Performance
Shares of NASDAQ PIII traded down $0.05 during trading on Thursday, reaching $2.69. 433 shares of the stock traded hands, compared to its average volume of 83,924. The stock has a market capitalization of $19.39 million, a P/E ratio of -0.06 and a beta of 0.56. P3 Health Partners has a 52-week low of $1.52 and a 52-week high of $11.30. The company has a 50-day moving average of $2.47 and a 200-day moving average of $5.05.
P3 Health Partners (NASDAQ:PIII – Get Free Report) last released its quarterly earnings data on Thursday, March 26th. The company reported ($23.02) EPS for the quarter, missing the consensus estimate of ($8.06) by ($14.96). P3 Health Partners had a negative return on equity of 302.33% and a negative net margin of 10.14%.The business had revenue of $384.81 million during the quarter, compared to the consensus estimate of $357.65 million. Analysts expect that P3 Health Partners will post -0.67 earnings per share for the current fiscal year.
Hedge Funds Weigh In On P3 Health Partners
A hedge fund recently raised its stake in P3 Health Partners stock. Trinity Financial Advisors LLC raised its position in shares of P3 Health Partners Inc. (NASDAQ:PIII – Free Report) by 4.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,678 shares of the company’s stock after buying an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned about 0.37% of P3 Health Partners worth $239,000 as of its most recent SEC filing. 7.75% of the stock is owned by institutional investors and hedge funds.
P3 Health Partners Company Profile
P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.
The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.